Skip to content
Screener

McKesson MCK Q1 2027 earnings

Reported August 5, 2026 · After market close

Revenue$105.38BBeat by $1.5B
Adjusted EPS$9.93Beat by $0.37
Revenue estimate$103.88B
EPS estimate$9.56
“McKesson delivered a strong start to fiscal 2027, underscored by momentum across the enterprise and disciplined execution against our strategic priorities. Our first quarter performance exceeded our expectations, highlighted by 20% growth in Adjusted Earnings per Diluted Share. It demonstrates the strength of our core distribution businesses, continued growth in oncology and multispecialty, and solid execution across our biopharma services platform. These results are a testament to the dedication of Team McKesson, whose commitment to excellence continues to drive our success and impact across healthcare. As we look ahead, we remain confident that our strategy and disciplined execution will continue to position McKesson for sustainable long-term growth and value creation.”
Brian Tyler

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$109.91B
EPS estimate$10.72

Financials

Q1 2027

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation & ratios

Valuation

as of 08/27/26
See full
Market cap$104.54B+23.0%
Enterprise value$112.25B+20.0%
P/E22.8×-4.1×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Current ratio0.9×0.0×

Segments

By segment

See full
North American Pharmaceutical$86.8B—
Oncology & Multispecialty$14.2B—
Medical-Surgical Solutions$2.8B+4.4%
Prescription Technology Solutions$1.6B+9.2%

FAQ

When did McKesson report Q1 2027 earnings?
McKesson (MCK) reported Q1 2027 earnings on August 5, 2026 after market close.
What were McKesson's Q1 2027 revenue and EPS?
McKesson reported revenue of $105.38B and adjusted eps of $9.93 for Q1 2027.
Did McKesson beat estimates in Q1 2027?
Revenue beat the consensus estimate of $103.88B by $1.5B. EPS beat the consensus estimate of $9.56 by $0.37.
How did McKesson's Q1 2027 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.7% from $97.8B a year earlier.
Where can I find McKesson's Q1 2027 SEC filings?
You can read the 8-K earnings release (0000927653-26-000232) and the 10-Q periodic report (0000927653-26-000234) directly on SEC EDGAR. The filing index links above go to sec.gov.